BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR System, and Enteric Bacterial Panel Diluent for BD COR System
K250358 is the FDA 510(k) clearance record for BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR System, and Enteric Bacterial Panel Diluent for BD COR System, a class II device, cleared for Becton, Dickinson and Company on under FDA product code PCI (Gastrointestinal Bacterial Panel Multiplex Nucleic Acid-Based Assay System). FDA's definition for product code PCI reads: "A gastrointestinal bacterial panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple gastrointestinal bacterial nucleic acids extracted from human stool...". FDA records list 345 510(k) clearances for Becton, Dickinson and Company, from to . As of , FDA records show no recalls naming K250358.
Clearance record
- Decision date
- Received
- (266 days to decision)
- Product code
- PCI Gastrointestinal Bacterial Panel Multiplex Nucleic Acid-Based Assay System
- Regulation
- 21 CFR 866.3990
- Device class
- Class II
- Review panel
- Microbiology
- Applicant
- Becton, Dickinson and Company 7loveton Cir., Sparks MD
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code PCI
Trailing 12 monthsFDA records hold no clearances under product code PCI in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
